{"id":48948,"date":"2022-09-29T08:01:54","date_gmt":"2022-09-29T06:01:54","guid":{"rendered":"https:\/\/pharma-trend.com\/en\/babylon-hires-andrew-hine-as-vice-president-of-the-europe-middle-east-africa-emea-asia-go-to-market-team\/"},"modified":"2022-09-29T08:01:54","modified_gmt":"2022-09-29T06:01:54","slug":"babylon-hires-andrew-hine-as-vice-president-of-the-europe-middle-east-africa-emea-asia-go-to-market-team","status":"publish","type":"post","link":"https:\/\/pharma-trend.com\/en\/babylon-hires-andrew-hine-as-vice-president-of-the-europe-middle-east-africa-emea-asia-go-to-market-team\/","title":{"rendered":"Babylon Hires Andrew Hine as Vice President of the Europe, Middle East, & Africa (EMEA) & Asia Go-to-Market Team"},"content":{"rendered":"
\n

\nDigital-first healthcare company grows leadership team to continue to amplify its presence in key markets.<\/i>\n<\/p>\n

AUSTIN, Texas & LONDON–(BUSINESS WIRE)–Babylon<\/a> (NYSE: BBLN) today announced the hiring of Andrew Hine as Vice President of the Go-to-Market team. Hine joins Babylon\u2019s Go-to-Market leadership team from Ernst & Young. In this role, Hine will lead the company\u2019s sales efforts in Asia and EMEA and he will work closely with Paul-Henri Ferrand, Babylon\u2019s Chief Operating Officer (COO), to oversee the execution of Babylon\u2019s overseas expansion.\n<\/p>\n

<\/a><\/p>\n

\nAs Babylon continues to strengthen its capabilities and enhance its presence in new and existing markets, Hine will lead the company\u2019s growing network of contracts, collaborations, and partnerships, as well as increase the scale of Babylon\u2019s service delivery and offerings.\n<\/p>\n

\n\u201cWe are delighted to have Andrew on board,\u201d said Paul-Henri Ferrand, COO of Babylon. \u201cAndrew\u2019s impressive experience and expertise in healthcare transformation will help further Babylon\u2019s mission as we build an integrated digital first primary care service that can manage global population health at scale.\u201d\n<\/p>\n

\nHine’s extensive healthcare background spans 30 years, 13 of which were spent as an NHS Operational Manager and Trust Board Director. He has led service delivery at the frontline in tertiary and secondary acute care, primary care, and mental health care services. Following his tenure with the NHS, Hine joined KPMG where he established and led its UK healthcare business as a consulting partner for 13 years, leading client engagements across the UK, Europe and the Middle East, particularly focusing on the strategic design, operational improvement and leadership of health services, organizations and systems.\n<\/p>\n

\nAfter KPMG, Hine joined Ernst & Young as the company\u2019s Head of Health for the Middle East and North Africa. He spent the last four years working extensively across Saudi Arabia, Qatar, and the United Arab Emirates.\n<\/p>\n

\n\u201cI have been fortunate to work at the frontline of healthcare delivery and within different health systems in various countries. These experiences have provided me with a profound understanding of the strengths and weaknesses of current healthcare delivery models around the world, the problems that need to be addressed, and the potential for new care models, processes, and technologies to dramatically improve the quality, accessibility, and costs of care,\u201d said Andrew Hine. \u201cI believe Babylon is making a significant impact within the healthcare space by providing better quality, more convenient, and lower cost care globally.\u201d\n<\/p>\n

\nFor more information, please visit https:\/\/www.babylonhealth.com\/press<\/a>.\n<\/p>\n

\nAbout Babylon<\/b>\n<\/p>\n

\nBabylon is one of the world\u2019s fastest growing digital healthcare companies whose mission is to make high-quality healthcare accessible and affordable for every person on Earth.\n<\/p>\n

\nBabylon is re-engineering how people engage with their care at every step of the healthcare continuum. By flipping the model from reactive sick care to proactive healthcare through the devices people already own, it offers millions of people globally ongoing, always-on care. Babylon has already shown that in environments as diverse as the developed UK or developing Rwanda, urban New York, or rural Missouri, for people of all ages, it is possible to achieve its mission by leveraging its highly scalable, digital-first platform combined with high quality, virtual clinical operations to provide integrated, personalized healthcare.\n<\/p>\n

\nFounded in 2013, Babylon\u2019s technology and clinical services is supporting a global patient network across 15 countries and is capable of operating in 16 languages. In 2021 alone, Babylon helped a patient every 6 seconds, with approximately 5.2 million consultations and AI interactions. Importantly, this was achieved with a 93% user retention rate in our NHS GP at Hand service and 4 or 5 star ratings from more than 90% of our users across all of our geographies.\n<\/p>\n

\nBabylon is also working with governments, health providers, employers and insurers across the globe to provide them with a new infrastructure that any partner can use to deliver high-quality healthcare with lower costs and better outcomes. For more information, please visit www.babylonhealth.com<\/a>.\n<\/p>\n

Contacts<\/b> <\/p>\n

\npress@babylonhealth.com<\/a>\n<\/p>\n<\/div>\n","protected":false},"excerpt":{"rendered":"

Digital-first healthcare company grows leadership team to continue to amplify its presence in key markets. AUSTIN, Texas & LONDON–(BUSINESS WIRE)–Babylon (NYSE: BBLN) today announced the hiring of Andrew Hine as Vice President of the Go-to-Market team. Hine joins Babylon\u2019s Go-to-Market leadership team from Ernst & Young. In this role, Hine will lead the company\u2019s sales … [Read more…]<\/a><\/span><\/p>\n","protected":false},"author":4,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[13],"tags":[],"class_list":{"0":"entry","1":"post","2":"publish","3":"author-business","4":"post-48948","6":"format-standard","7":"category-industry"},"yoast_head":"\nBabylon Hires Andrew Hine as Vice President of the Europe, Middle East, & Africa (EMEA) & Asia Go-to-Market Team - Pharma Trend<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/pharma-trend.com\/en\/babylon-hires-andrew-hine-as-vice-president-of-the-europe-middle-east-africa-emea-asia-go-to-market-team\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Babylon Hires Andrew Hine as Vice President of the Europe, Middle East, & Africa (EMEA) & Asia Go-to-Market Team - Pharma Trend\" \/>\n<meta property=\"og:description\" content=\"Digital-first healthcare company grows leadership team to continue to amplify its presence in key markets. AUSTIN, Texas & LONDON–(BUSINESS WIRE)–Babylon (NYSE: BBLN) today announced the hiring of Andrew Hine as Vice President of the Go-to-Market team. Hine joins Babylon\u2019s Go-to-Market leadership team from Ernst & Young. In this role, Hine will lead the company\u2019s sales ... [Read more...]\" \/>\n<meta property=\"og:url\" content=\"https:\/\/pharma-trend.com\/en\/babylon-hires-andrew-hine-as-vice-president-of-the-europe-middle-east-africa-emea-asia-go-to-market-team\/\" \/>\n<meta property=\"og:site_name\" content=\"Pharma Trend\" \/>\n<meta property=\"article:published_time\" content=\"2022-09-29T06:01:54+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/mms.businesswire.com\/media\/20220928005831\/en\/1585906\/21\/BLYN_GBL_BRD_Horizontal_Logo_White_1920x1080_JUL20_%281%29.jpg\" \/>\n<meta name=\"author\" content=\"Business Wire\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Business Wire\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"3 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/babylon-hires-andrew-hine-as-vice-president-of-the-europe-middle-east-africa-emea-asia-go-to-market-team\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/babylon-hires-andrew-hine-as-vice-president-of-the-europe-middle-east-africa-emea-asia-go-to-market-team\\\/\"},\"author\":{\"name\":\"Business Wire\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#\\\/schema\\\/person\\\/02d41342c7a74fa7f0032bb35ef0bb24\"},\"headline\":\"Babylon Hires Andrew Hine as Vice President of the Europe, Middle East, & Africa (EMEA) & Asia Go-to-Market Team\",\"datePublished\":\"2022-09-29T06:01:54+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/babylon-hires-andrew-hine-as-vice-president-of-the-europe-middle-east-africa-emea-asia-go-to-market-team\\\/\"},\"wordCount\":671,\"publisher\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#organization\"},\"image\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/babylon-hires-andrew-hine-as-vice-president-of-the-europe-middle-east-africa-emea-asia-go-to-market-team\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/mms.businesswire.com\\\/media\\\/20220928005831\\\/en\\\/1585906\\\/21\\\/BLYN_GBL_BRD_Horizontal_Logo_White_1920x1080_JUL20_%281%29.jpg\",\"articleSection\":[\"Industry\"],\"inLanguage\":\"en-US\"},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/babylon-hires-andrew-hine-as-vice-president-of-the-europe-middle-east-africa-emea-asia-go-to-market-team\\\/\",\"url\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/babylon-hires-andrew-hine-as-vice-president-of-the-europe-middle-east-africa-emea-asia-go-to-market-team\\\/\",\"name\":\"Babylon Hires Andrew Hine as Vice President of the Europe, Middle East, & Africa (EMEA) & Asia Go-to-Market Team - Pharma Trend\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/babylon-hires-andrew-hine-as-vice-president-of-the-europe-middle-east-africa-emea-asia-go-to-market-team\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/babylon-hires-andrew-hine-as-vice-president-of-the-europe-middle-east-africa-emea-asia-go-to-market-team\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/mms.businesswire.com\\\/media\\\/20220928005831\\\/en\\\/1585906\\\/21\\\/BLYN_GBL_BRD_Horizontal_Logo_White_1920x1080_JUL20_%281%29.jpg\",\"datePublished\":\"2022-09-29T06:01:54+00:00\",\"breadcrumb\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/babylon-hires-andrew-hine-as-vice-president-of-the-europe-middle-east-africa-emea-asia-go-to-market-team\\\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/pharma-trend.com\\\/en\\\/babylon-hires-andrew-hine-as-vice-president-of-the-europe-middle-east-africa-emea-asia-go-to-market-team\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/babylon-hires-andrew-hine-as-vice-president-of-the-europe-middle-east-africa-emea-asia-go-to-market-team\\\/#primaryimage\",\"url\":\"https:\\\/\\\/mms.businesswire.com\\\/media\\\/20220928005831\\\/en\\\/1585906\\\/21\\\/BLYN_GBL_BRD_Horizontal_Logo_White_1920x1080_JUL20_%281%29.jpg\",\"contentUrl\":\"https:\\\/\\\/mms.businesswire.com\\\/media\\\/20220928005831\\\/en\\\/1585906\\\/21\\\/BLYN_GBL_BRD_Horizontal_Logo_White_1920x1080_JUL20_%281%29.jpg\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/babylon-hires-andrew-hine-as-vice-president-of-the-europe-middle-east-africa-emea-asia-go-to-market-team\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Startseite\",\"item\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Babylon Hires Andrew Hine as Vice President of the Europe, Middle East, & Africa (EMEA) & Asia Go-to-Market Team\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#website\",\"url\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/\",\"name\":\"Pharma Trend\",\"description\":\"\",\"publisher\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Organization\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#organization\",\"name\":\"Pharma Trend\",\"url\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#\\\/schema\\\/logo\\\/image\\\/\",\"url\":\"\",\"contentUrl\":\"\",\"caption\":\"Pharma Trend\"},\"image\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#\\\/schema\\\/logo\\\/image\\\/\"}},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#\\\/schema\\\/person\\\/02d41342c7a74fa7f0032bb35ef0bb24\",\"name\":\"Business Wire\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Babylon Hires Andrew Hine as Vice President of the Europe, Middle East, & Africa (EMEA) & Asia Go-to-Market Team - Pharma Trend","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/pharma-trend.com\/en\/babylon-hires-andrew-hine-as-vice-president-of-the-europe-middle-east-africa-emea-asia-go-to-market-team\/","og_locale":"en_US","og_type":"article","og_title":"Babylon Hires Andrew Hine as Vice President of the Europe, Middle East, & Africa (EMEA) & Asia Go-to-Market Team - Pharma Trend","og_description":"Digital-first healthcare company grows leadership team to continue to amplify its presence in key markets. AUSTIN, Texas & LONDON–(BUSINESS WIRE)–Babylon (NYSE: BBLN) today announced the hiring of Andrew Hine as Vice President of the Go-to-Market team. Hine joins Babylon\u2019s Go-to-Market leadership team from Ernst & Young. In this role, Hine will lead the company\u2019s sales ... [Read more...]","og_url":"https:\/\/pharma-trend.com\/en\/babylon-hires-andrew-hine-as-vice-president-of-the-europe-middle-east-africa-emea-asia-go-to-market-team\/","og_site_name":"Pharma Trend","article_published_time":"2022-09-29T06:01:54+00:00","og_image":[{"url":"https:\/\/mms.businesswire.com\/media\/20220928005831\/en\/1585906\/21\/BLYN_GBL_BRD_Horizontal_Logo_White_1920x1080_JUL20_%281%29.jpg","type":"","width":"","height":""}],"author":"Business Wire","twitter_card":"summary_large_image","twitter_misc":{"Written by":"Business Wire","Est. reading time":"3 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/pharma-trend.com\/en\/babylon-hires-andrew-hine-as-vice-president-of-the-europe-middle-east-africa-emea-asia-go-to-market-team\/#article","isPartOf":{"@id":"https:\/\/pharma-trend.com\/en\/babylon-hires-andrew-hine-as-vice-president-of-the-europe-middle-east-africa-emea-asia-go-to-market-team\/"},"author":{"name":"Business Wire","@id":"https:\/\/pharma-trend.com\/en\/#\/schema\/person\/02d41342c7a74fa7f0032bb35ef0bb24"},"headline":"Babylon Hires Andrew Hine as Vice President of the Europe, Middle East, & Africa (EMEA) & Asia Go-to-Market Team","datePublished":"2022-09-29T06:01:54+00:00","mainEntityOfPage":{"@id":"https:\/\/pharma-trend.com\/en\/babylon-hires-andrew-hine-as-vice-president-of-the-europe-middle-east-africa-emea-asia-go-to-market-team\/"},"wordCount":671,"publisher":{"@id":"https:\/\/pharma-trend.com\/en\/#organization"},"image":{"@id":"https:\/\/pharma-trend.com\/en\/babylon-hires-andrew-hine-as-vice-president-of-the-europe-middle-east-africa-emea-asia-go-to-market-team\/#primaryimage"},"thumbnailUrl":"https:\/\/mms.businesswire.com\/media\/20220928005831\/en\/1585906\/21\/BLYN_GBL_BRD_Horizontal_Logo_White_1920x1080_JUL20_%281%29.jpg","articleSection":["Industry"],"inLanguage":"en-US"},{"@type":"WebPage","@id":"https:\/\/pharma-trend.com\/en\/babylon-hires-andrew-hine-as-vice-president-of-the-europe-middle-east-africa-emea-asia-go-to-market-team\/","url":"https:\/\/pharma-trend.com\/en\/babylon-hires-andrew-hine-as-vice-president-of-the-europe-middle-east-africa-emea-asia-go-to-market-team\/","name":"Babylon Hires Andrew Hine as Vice President of the Europe, Middle East, & Africa (EMEA) & Asia Go-to-Market Team - Pharma Trend","isPartOf":{"@id":"https:\/\/pharma-trend.com\/en\/#website"},"primaryImageOfPage":{"@id":"https:\/\/pharma-trend.com\/en\/babylon-hires-andrew-hine-as-vice-president-of-the-europe-middle-east-africa-emea-asia-go-to-market-team\/#primaryimage"},"image":{"@id":"https:\/\/pharma-trend.com\/en\/babylon-hires-andrew-hine-as-vice-president-of-the-europe-middle-east-africa-emea-asia-go-to-market-team\/#primaryimage"},"thumbnailUrl":"https:\/\/mms.businesswire.com\/media\/20220928005831\/en\/1585906\/21\/BLYN_GBL_BRD_Horizontal_Logo_White_1920x1080_JUL20_%281%29.jpg","datePublished":"2022-09-29T06:01:54+00:00","breadcrumb":{"@id":"https:\/\/pharma-trend.com\/en\/babylon-hires-andrew-hine-as-vice-president-of-the-europe-middle-east-africa-emea-asia-go-to-market-team\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/pharma-trend.com\/en\/babylon-hires-andrew-hine-as-vice-president-of-the-europe-middle-east-africa-emea-asia-go-to-market-team\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/pharma-trend.com\/en\/babylon-hires-andrew-hine-as-vice-president-of-the-europe-middle-east-africa-emea-asia-go-to-market-team\/#primaryimage","url":"https:\/\/mms.businesswire.com\/media\/20220928005831\/en\/1585906\/21\/BLYN_GBL_BRD_Horizontal_Logo_White_1920x1080_JUL20_%281%29.jpg","contentUrl":"https:\/\/mms.businesswire.com\/media\/20220928005831\/en\/1585906\/21\/BLYN_GBL_BRD_Horizontal_Logo_White_1920x1080_JUL20_%281%29.jpg"},{"@type":"BreadcrumbList","@id":"https:\/\/pharma-trend.com\/en\/babylon-hires-andrew-hine-as-vice-president-of-the-europe-middle-east-africa-emea-asia-go-to-market-team\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Startseite","item":"https:\/\/pharma-trend.com\/en\/"},{"@type":"ListItem","position":2,"name":"Babylon Hires Andrew Hine as Vice President of the Europe, Middle East, & Africa (EMEA) & Asia Go-to-Market Team"}]},{"@type":"WebSite","@id":"https:\/\/pharma-trend.com\/en\/#website","url":"https:\/\/pharma-trend.com\/en\/","name":"Pharma Trend","description":"","publisher":{"@id":"https:\/\/pharma-trend.com\/en\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/pharma-trend.com\/en\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Organization","@id":"https:\/\/pharma-trend.com\/en\/#organization","name":"Pharma Trend","url":"https:\/\/pharma-trend.com\/en\/","logo":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/pharma-trend.com\/en\/#\/schema\/logo\/image\/","url":"","contentUrl":"","caption":"Pharma Trend"},"image":{"@id":"https:\/\/pharma-trend.com\/en\/#\/schema\/logo\/image\/"}},{"@type":"Person","@id":"https:\/\/pharma-trend.com\/en\/#\/schema\/person\/02d41342c7a74fa7f0032bb35ef0bb24","name":"Business Wire"}]}},"_links":{"self":[{"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/posts\/48948","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/users\/4"}],"replies":[{"embeddable":true,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/comments?post=48948"}],"version-history":[{"count":0,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/posts\/48948\/revisions"}],"wp:attachment":[{"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/media?parent=48948"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/categories?post=48948"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/tags?post=48948"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}